Two Studies Challenge Avastin’s Effectiveness Against a Rare Brain Cancer
Monday, June 3, 2013 - 16:20
in Health & Medicine
The findings could lead the F.D.A. to revoke the drug’s approval for the treatment of glioblastoma, a rare brain cancer.